Focal segmental glomerulosclerosis (NORD)

Last updated: February 23, 2023

Focal segmental glomerulosclerosis (NORD)

מערכות א

מערכות א

Hyponatremia: Clinical
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Hyperkalemia: Clinical
Hyperkalemia
Hypokalemia
Hypokalemia: Clinical
Chronic kidney disease: Clinical
Chronic kidney disease
Renal failure: Pathology review
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Acute kidney injury: Clinical
Nephritic and nephrotic syndromes: Clinical
Phosphate, calcium and magnesium homeostasis
ACE inhibitors, ARBs and direct renin inhibitors
Potassium sparing diuretics
Loop diuretics
Thiazide and thiazide-like diuretics
Osmotic diuretics
Heart failure: Clinical
Hyperaldosteronism
Diabetes insipidus and SIADH: Pathology review
Hyponatremia
Non-steroidal anti-inflammatory drugs
Asthma: Clinical
Alport syndrome
Metabolic and respiratory alkalosis: Clinical
The role of the kidney in acid-base balance
Minimal change disease
Focal segmental glomerulosclerosis (NORD)
Membranous nephropathy
Membranoproliferative glomerulonephritis
Amyloidosis
Lupus nephritis
Rapidly progressive glomerulonephritis
IgA nephropathy (NORD)
Poststreptococcal glomerulonephritis
Acid-base disturbances: Pathology review
Renal tubular acidosis: Pathology review
Acid-base map and compensatory mechanisms
Aortic valve disease
Mitral valve disease
Dilated cardiomyopathy
Valvular heart disease: Clinical
Cardiomyopathies: Pathology review
Restrictive cardiomyopathy
Hypertrophic cardiomyopathy
Atherosclerosis and arteriosclerosis: Pathology review
Heart failure: Pathology review
Calcium channel blockers
Lipid-lowering medications: Statins
Myocardial infarction
ECG cardiac infarction and ischemia
Coronary artery disease: Clinical
Coronary artery disease: Pathology review
Coronary steal syndrome
Atrial fibrillation
Atrioventricular nodal reentrant tachycardia (AVNRT)
Heart blocks: Pathology review
ECG cardiac hypertrophy and enlargement
Valvular heart disease: Pathology review
Supraventricular arrhythmias: Pathology review
Hypertension: Pathology review
Vasculitis: Pathology review

Transcript

Watch video only

Content Reviewers

Focal segmental glomerulosclerosis, or sometimes focal glomerular sclerosis, or just sometimes FSGS, is a type of kidney disease that affects the kidney’s glomeruli, which is where small molecules are first filtered out of blood and into the urine.

From the name, you have glomerulosclerosis, which indicates sclerosis, or scar tissue, forming in the glomeruli.

Segmental means that only a segment, or part of the glomeruli is affected, and focal means that among all those glomeruli in the kidney, only some are affected.

Those glomeruli that are affected, though, allow proteins to filter through into the urine, and ultimately people with FSGS develop nephrotic syndrome.

But what exactly is nephrotic syndrome? Well usually the glomerulus only lets small molecules, like sodium and water, move from the blood into the kidney nephron, where it eventually makes its way into the urine. But with nephrotic syndromes, the glomeruli are damaged and they become more permeable, so they start letting plasma proteins come across from the blood to the nephron and then into the urine, which causes proteinuria, typically greater than 3.5 grams per day.

An important protein in the blood is albumin, and so when it starts leaving the blood, people get hypoalbuminemia—low albumin in the blood.

With less protein in the blood the oncotic pressure falls, which lowers the overall osmotic pressure, which drives water out of the blood vessels and into the tissues, called edema.

Finally, it’s thought that as a result of either losing albumin or losing some protein or proteins that inhibit the synthesis of lipids, or fat, you get increased levels of lipids in the blood, called hyperlipidemia.

Just like the proteins, these lipids can also get into the urine, causing lipiduria.

And those are the hallmarks of nephrotic syndrome—proteinuria, hypoalbuminemia, edema, hyperlipidemia, and lipiduria.

So focal segmental glomerulosclerosis is a type of nephrotic syndrome, that’s helpful, but why does the glomerulus develop segmental sclerosis in the first place?

Well, primary FSGS is when it’s idiopathic, or there’s no clear underlying cause.

What is known, though, is that the podocytes, which are the cells that have these long tentacle-like projections, called foot processes, that wrap around the capillaries in the glomeruli, are damaged. These damaged podocytes allow some plasma proteins and lipids to sneak by, which then go on to get into the urine.

Not only that though, over time, some of these proteins and lipids to get trapped and build up in the glomerulus, resulting in hyalinosis, where the tissue has a hyaline or glassy appearance on histology, and it’s thought that over time these areas move on to develop sclerosis, or scar tissue.

Key Takeaways

Focal segmental glomerulosclerosis (FSGS) is a cause of nephrotic syndrome in children and adolescents, as well as a leading cause of kidney failure in adults. It accounts for about a sixth of the cases of nephrotic syndrome.